Form 6-K Theratechnologies Inc. For: Sep 18
Theratechnologies Inc. - Common Shares (THTX)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
THTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
THTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
THTX alerts
High impacting Theratechnologies Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
THTX
News
- Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROIGlobeNewswire
- Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIVGlobeNewswire
- Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024GlobeNewswire
- Theratechnologies Inc. (NASDAQ: THTX) was upgraded by analysts at Research Capitl to a "strong-buy" rating.MarketBeat
- Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update [Canadian Business Journal (Canada)]Canadian Business Journal
THTX
Analyst Actions
- 2/14/25 - MACKIE RESEARCH
THTX
Sec Filings
- 2/26/25 - Form 20-F
- 2/26/25 - Form 6-K
- 2/21/25 - Form 6-K
- THTX's page on the SEC website